PEDERZOLI, FILIPPO
 Distribuzione geografica
Continente #
EU - Europa 1.711
AS - Asia 1.573
NA - Nord America 1.573
SA - Sud America 386
Continente sconosciuto - Info sul continente non disponibili 98
AF - Africa 38
OC - Oceania 2
Totale 5.381
Nazione #
US - Stati Uniti d'America 1.494
RU - Federazione Russa 993
SG - Singapore 454
CN - Cina 435
HK - Hong Kong 333
BR - Brasile 320
IT - Italia 178
SE - Svezia 178
VN - Vietnam 155
DE - Germania 100
FR - Francia 72
CA - Canada 48
GB - Regno Unito 48
FI - Finlandia 47
BD - Bangladesh 43
IN - India 36
AR - Argentina 26
NL - Olanda 24
PL - Polonia 22
MX - Messico 21
JP - Giappone 18
ID - Indonesia 17
ZA - Sudafrica 14
TR - Turchia 13
EC - Ecuador 11
EG - Egitto 10
ES - Italia 10
IE - Irlanda 10
IQ - Iraq 9
PY - Paraguay 9
AT - Austria 8
CO - Colombia 8
IR - Iran 8
MY - Malesia 8
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
JM - Giamaica 5
MA - Marocco 5
PK - Pakistan 5
VE - Venezuela 5
LT - Lituania 4
NP - Nepal 4
TN - Tunisia 4
UA - Ucraina 4
EU - Europa 3
JO - Giordania 3
KE - Kenya 3
NI - Nicaragua 3
SA - Arabia Saudita 3
TW - Taiwan 3
XK - ???statistics.table.value.countryCode.XK??? 3
AU - Australia 2
BE - Belgio 2
CH - Svizzera 2
CL - Cile 2
CZ - Repubblica Ceca 2
IL - Israele 2
KR - Corea 2
KW - Kuwait 2
PH - Filippine 2
UY - Uruguay 2
BB - Barbados 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CY - Cipro 1
DZ - Algeria 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LY - Libia 1
MK - Macedonia 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
SR - Suriname 1
TH - Thailandia 1
Totale 5.289
Città #
Hong Kong 330
Singapore 228
Moscow 205
Ashburn 180
Dallas 171
San Jose 131
New York 95
Shanghai 76
Beijing 64
Council Bluffs 61
Ho Chi Minh City 57
Los Angeles 56
Hefei 53
Milan 45
Lauterbourg 41
Santa Clara 39
Lawrence 38
Princeton 38
Munich 32
Hanoi 31
Boardman 29
Rome 28
São Paulo 26
Orem 21
Turku 21
Montreal 20
Denver 18
Helsinki 18
Frankfurt am Main 16
Warsaw 16
Atlanta 14
Tokyo 13
Houston 12
Mumbai 12
Nuremberg 12
Chennai 11
Guangzhou 11
Amsterdam 10
Brooklyn 10
Da Nang 10
Dublin 10
Haiphong 10
London 10
Phoenix 10
Poplar 10
Rio de Janeiro 10
Johannesburg 9
San Francisco 9
Toronto 9
Chicago 8
Salvador 8
Seattle 8
Stockholm 8
Cairo 7
Hanover 7
Lappeenranta 7
Mexico City 7
Turin 7
Boston 6
Brasília 6
Cesano Boscone 6
Charlotte 6
Columbus 6
Querétaro 6
Ankara 5
Buffalo 5
Caxias do Sul 5
Guayaquil 5
Indpls 5
Manchester 5
Memphis 5
The Dalles 5
Verona 5
Biên Hòa 4
Can Tho 4
Chengdu 4
City of London 4
Concord 4
Curitiba 4
Fortaleza 4
Hangzhou 4
Kingston 4
Medellín 4
Naples 4
New Delhi 4
Porto Alegre 4
Pune 4
Quito 4
Segrate 4
São José do Rio Preto 4
Tashkent 4
Vienna 4
Barnet 3
Barueri 3
Bekasi 3
Belo Horizonte 3
Cape Town 3
Catania 3
Cleveland 3
Detroit 3
Totale 2.634
Nome #
[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab 236
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 163
Microbiome and bladder cancer 160
Normal sperm parameters per se do not reliably account for fertility: A case–control study in the real-life setting 149
Aging, inflammation and DNA damage in the somatic testicular niche with idiopathic germ cell aplasia 149
Efficacy and toxicity of antibody-drug conjugates in the treatment of metastatic urothelial cancer: A scoping review 142
A global approach to improving penile cancer care 141
Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer 135
Gold nanorod–assisted theranostic solution for nonvisible residual disease in bladder cancer 134
Testicular volume in infertile versus fertile white-European men: a case-control investigation in the real-life setting 134
Infertile Men Have Higher Prostate-specific Antigen Values than Fertile Individuals of Comparable Age 128
Clinical Profile of Young Patients with Erectile Dysfunction: Preliminary Findings of a Real-life Cross-sectional Study 126
Stool Microbiome Signature Associated with Response to Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Cancer 125
Association Between Human Papillomavirus Infection and Outcome of Perioperative Nodal Radiotherapy for Penile Carcinoma 122
Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study☆ 120
A risk calculator predicting recurrence in lymph node metastatic penile cancer 118
Early diagnosis of bladder cancer by photoacoustic imaging of tumor-targeted gold nanorods 117
Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study) 113
Causal contributors to tissue stiffness and clinical relevance in urology 113
Re: Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-Invasive Bladder Carcinoma with Variant Histologies 112
Contemporary Treatment Patterns and Outcomes for Patients with Penile Squamous Cell Carcinoma: Identifying Management Gaps to Promote Multi-institutional Collaboration 110
Heavy cigarette smoking and alcohol consumption are associated with impaired sperm parameters in primary infertile men 109
Incidence and Clinical Impact of Inflammatory Fluorodeoxyglucose Positron Emission Tomography Uptake After Neoadjuvant Pembrolizumab in Patients with Organ-confined Bladder Cancer Undergoing Radical Cystectomy 109
Leiomyoadenomatoid tumours of the epididymis: A new case report and review of the literature 105
Perioperative and oncologic outcomes of open radical nephrectomy and inferior vena cava thrombectomy with liver mobilization and Pringle maneuver for Mayo III level tumor thrombus: single institution experience 105
Unfavorable Cancer-specific Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients With Bladder Cancer and Squamous Cell Variant: A Multi-institutional Study 104
Bladder-sparing combination treatments for muscle-invasive bladder cancer: A plea for standardized assessment and definition of clinical trials endpoints 103
Is There a Detrimental Effect of Antibiotic Therapy in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Pembrolizumab? 100
Re: Siamak Daneshmand, Azadeh Nazemi. Neoadjuvant Chemotherapy in Variant Histology Bladder Cancer: Current Evidence. Eur Urol Focus 2020;6:639–41 97
High-risk Surgically Resected Renal Cell Carcinoma: Is There a Role for Adjuvant VEGF-TKI Inhibitors? 95
Topographic modification of the extracellular matrix precedes the onset of bladder cancer 91
Intermediate- and high-risk nonmuscle invasive bladder cancer: Where do we stand? 88
Can Patients with Muscle-invasive Bladder Cancer and Fibroblast Growth Factor Receptor-3 Alterations Still Be Considered for Neoadjuvant Pembrolizumab? A Comprehensive Assessment from the Updated Results of the PURE-01 Study 87
Risk factors and survival outcomes for upstaging after inguinal lymph node dissection for cN1 penile squamous cell carcinoma 83
Sex-specific Alterations in the Urinary and Tissue Microbiome in Therapy-naïve Urothelial Bladder Cancer Patients 80
Risk of health status worsening in primary infertile men: A prospective 10-year follow-up study 78
Re: High blood pressure is a highly prevalent but unrecognised condition in primary infertile men: Results of a cross-sectional study 73
Neoadjuvant chemotherapy for lymph node-positive penile cancer: Current evidence and knowledge 72
Revolutionizing care for rare genitourinary tumours 72
Progressive alteration of murine bladder elasticity in actinic cystitis detected by Brillouin microscopy 71
Micro-mechanical fingerprints of the rat bladder change in actinic cystitis and tumor presence 70
Targetable gene fusions and aberrations in genitourinary oncology 70
Regenerative and engineered options for urethroplasty 65
Neoadjuvant Chemotherapy or Immunotherapy for Clinical T2N0 Muscle-invasive Bladder Cancer: Time to Change the Paradigm? 64
Semen infections in men with primary infertility in the real-life setting 62
Optimising the selection of candidates for neoadjuvant chemotherapy amongst patients with node-positive penile squamous cell carcinoma 62
The new era of precision urobiome: RE: “Characterization of urinary microbiome in patients with bladder cancer: Results from a single-institution, feasibility study” by Chipollini et al 60
The Gut and Urinary Microbiota: A Rising Biomarker in Genitourinary Malignancies 59
Re: Undiagnosed Prediabetes is Highly Prevalent in Primary Infertile Men-Results from a Cross-Sectional Study 58
Patterns of Recurrence following Inguinal Lymph Node Dissection for Penile Cancer: Optimizing Surveillance Strategies 57
Whole exome data prioritization unveils the hidden weight of Mendelian causes of male infertility. A report from the first Italian cohort 56
The Value of Multiparametric Magnetic Resonance Imaging Sequences to Assist in the Decision Making of Muscle-invasive Bladder Cancer 56
Predicting the pathologic complete response after neoadjuvant pembrolizumab in muscle-invasive bladder cancer 55
Testis Molecular Pathways in CAIS Unveil Testosterone/Estradiol on Germ Cell Tumor Risk in Non-Obstructive Azoospermia 12
null 1
null 1
null 1
null 1
null 1
null 1
Totale 5.381
Categoria #
all - tutte 26.249
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.249


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022101 0 10 2 20 3 4 15 9 5 7 3 23
2022/2023319 93 71 26 16 5 36 11 26 15 5 5 10
2023/2024320 11 28 34 31 30 74 10 41 1 4 8 48
2024/20251.146 100 42 16 41 61 78 188 269 123 83 57 88
2025/20263.177 192 239 224 415 288 99 225 217 893 145 80 160
2026/2027290 170 120 0 0 0 0 0 0 0 0 0 0
Totale 5.381